Innopharma Insights - Volume 2
| dc.contributor.author | Innopharma Insights Editorial Team | |
| dc.date.accessioned | 2025-12-04T15:26:22Z | |
| dc.date.available | 2025-12-04T15:26:22Z | |
| dc.date.issued | 2025-12 | |
| dc.description.abstract | Volume 2 of Innopharma Insights compiles key contributions from Innopharma Education learners and staff, focusing on advancements in Ireland's biopharmaceutical sector, digital health compliance, vaccine hesitancy strategies, antiviral drug discovery, medical imaging equity, clinical trial digitalisation, and psychobiotic interventions for mental health. Highlights include a review of the 2025 BioPharmaChem Impact Conference, emphasising talent development, sustainability, and Innopharma Technical Services' award for Best Talent Strategy; analyses of regulatory challenges in diabetes management technologies; empirical studies on parental trust in measles vaccination sources amid Ireland's outbreaks; computational optimisation of Tinosporaside derivatives as dual SARS-CoV-2 protease inhibitors; comparative radiographer experiences with CT scanners in Ireland and Sub-Saharan Africa; feasibility of wearable sensors in 6-minute walk tests for trials; and psychobiotic diets targeting the gut-brain axis for stress and depression. These interdisciplinary works underscore Innopharma's role in bridging education, industry needs, and innovative research to address regulatory, technological, and health equity challenges in life. | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14136/279 | |
| dc.title | Innopharma Insights - Volume 2 | |
| dc.type | Other |